MPLT MapLight Therapeutics, Inc.

NASDAQ
$6.90

MapLight Therapeutics, Inc. (MPLT) SEC Filings

Everything MPLT has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

100 filings
Date Form Filing
SCHEDULE 13G/A
8-K Capital Raise · Material Agreement
SCHEDULE 13G/A
10-Q
8-K Capital Raise · Earnings Release · Guidance Update · Investor Presentation · Reg Fd · Restructuring
4
4
4
4
4
4
144
144
144
144
144
144
144
4
144
SCHEDULE 13G
4
4
4
4
4
4
4
SCHEDULE 13D/A
10-Q
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-K
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.